Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lastres-Becker

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The European Journal of Neuroscience|February 28, 2002
Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosetsI Lastres-Becker, M Cebeira, M L de Ceballos, et al.
Life Sciences|August 14, 1999
Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamideS González, J Romero, R de Miguel, et al.
Free Radical Biology & Medicine|January 15, 2026
NRF2 AT THE CROSSROADS OF PARKINSON'S DISEASE AND AGING: MECHANISTIC INSIGHTS AND TRANSLATIONAL PERSPECTIVESGarcía-Yagüe Áj, Esteras N, A T Dinkova-Kostova, et al.
Journal of Neurochemistry|October 2, 2001
Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegenerationH H Hansen, P C Schmid, P Bittigau, et al.
Acta Neuropathologica Communications|May 18, 2021
Cannabinoid receptor CB2 ablation protects against TAU induced neurodegenerationM Galán-Ganga, C Rodríguez-Cueto, J Merchán-Rubira, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The European Journal of Neuroscience|February 28, 2002
Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosetsI Lastres-Becker, M Cebeira, M L de Ceballos, et al.
Life Sciences|August 14, 1999
Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamideS González, J Romero, R de Miguel, et al.
Free Radical Biology & Medicine|January 15, 2026
NRF2 AT THE CROSSROADS OF PARKINSON'S DISEASE AND AGING: MECHANISTIC INSIGHTS AND TRANSLATIONAL PERSPECTIVESGarcía-Yagüe Áj, Esteras N, A T Dinkova-Kostova, et al.
Journal of Neurochemistry|October 2, 2001
Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegenerationH H Hansen, P C Schmid, P Bittigau, et al.
Acta Neuropathologica Communications|May 18, 2021
Cannabinoid receptor CB2 ablation protects against TAU induced neurodegenerationM Galán-Ganga, C Rodríguez-Cueto, J Merchán-Rubira, et al.
Pageof 2